This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1il6
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1il6.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1il6| PDB=1il6 | SCENE= }} | {{STRUCTURE_1il6| PDB=1il6 | SCENE= }} | ||
| - | |||
===HUMAN INTERLEUKIN-6, NMR, MINIMIZED AVERAGE STRUCTURE=== | ===HUMAN INTERLEUKIN-6, NMR, MINIMIZED AVERAGE STRUCTURE=== | ||
| + | {{ABSTRACT_PUBMED_9159484}} | ||
| - | + | ==Disease== | |
| + | [[http://www.uniprot.org/uniprot/IL6_HUMAN IL6_HUMAN]] Genetic variations in IL6 are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:[http://omim.org/entry/604302 604302]]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis. Note=A IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in HIV-infected men. | ||
| + | |||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/IL6_HUMAN IL6_HUMAN]] Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance. | ||
==About this Structure== | ==About this Structure== | ||
| Line 14: | Line 16: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:009159484</ref><references group="xtra"/> | + | <ref group="xtra">PMID:009159484</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Cumming, D A.]] | [[Category: Cumming, D A.]] | ||
Revision as of 20:43, 24 March 2013
Contents |
HUMAN INTERLEUKIN-6, NMR, MINIMIZED AVERAGE STRUCTURE
Template:ABSTRACT PUBMED 9159484
Disease
[IL6_HUMAN] Genetic variations in IL6 are associated with susceptibility to rheumatoid arthritis systemic juvenile (RASJ) [MIM:604302]. An inflammatory articular disorder with systemic-onset beginning before the age of 16. It represents a subgroup of juvenile arthritis associated with severe extraarticular features and occasionally fatal complications. During active phases of the disorder, patients display a typical daily spiking fever, an evanescent macular rash, lymphadenopathy, hepatosplenomegaly, serositis, myalgia and arthritis. Note=A IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in HIV-infected men.
Function
[IL6_HUMAN] Cytokine with a wide variety of biological functions. It is a potent inducer of the acute phase response. Plays an essential role in the final differentiation of B-cells into Ig-secreting cells Involved in lymphocyte and monocyte differentiation. It induces myeloma and plasmacytoma growth and induces nerve cells differentiation Acts on B-cells, T-cells, hepatocytes, hematopoietic progenitor cells and cells of the CNS. Also acts as a myokine. It is discharged into the bloodstream after muscle contraction and acts to increase the breakdown of fats and to improve insulin resistance.
About this Structure
1il6 is a 1 chain structure with sequence from Homo sapiens. Full experimental information is available from OCA.
See Also
Reference
- Xu GY, Yu HA, Hong J, Stahl M, McDonagh T, Kay LE, Cumming DA. Solution structure of recombinant human interleukin-6. J Mol Biol. 1997 May 2;268(2):468-81. PMID:9159484 doi:10.1006/jmbi.1997.0933
Categories: Homo sapiens | Cumming, D A. | Hong, J. | Kay, L E. | Mcdonagh, T. | Stahl, M. | Xu, G Y. | Yu, H A. | Cytokine | Glycoprotein | Growth factor
